The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Topography of cancer-associated immune cells in human solid tumors
Open accessAbstract
Lymphoid and myeloid cells are abundant in the tumor microenvironment, can be quantified by immunohistochemistry and shape the disease course of human solid tumors. Yet, there is no comprehensive understanding of spatial immune infiltration patterns (‘topography’) across cancer entities and across various immune cell types. In this study, we systematically measure the topography of multiple immune cell types in 965 histological tissue slides from N = 177 patients in a pan-cancer cohort. We provide a definition of inflamed (‘hot’), non-inflamed (‘cold’) and immune excluded patterns and investigate how these patterns differ between immune cell types and between cancer types. In an independent cohort of N = 287 colorectal cancer patients, we show that hot, cold and excluded topographies for effector lymphocytes (CD8) and tumor-associated macrophages (CD163) alone are not prognostic, but that a bivariate classification system can stratify patients. Our study adds evidence to consider immune topographies as biomarkers for patients with solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Davies, D. L., & Bouldin, D. W. (1979) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.1979.4766909 · Cited by 9,145
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Self-citationOncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929 · cited 1×
“One of the key strategies is that tumor cells interfere with immune signaling, hijacking immunosuppressive cells and thereby shaping the immune infiltrate, which allows for tumor cell proliferation (Chen and Mellman, 2013; Chen and Mellman, 2017).”
BackgroundType, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 4×
“Multiple immune cell types are involved in this system and ultimately shift it towards a tumor-promoting or tumor-rejecting environment (Chen and Mellman, 2017; Fridman et al., 2017).”
BackgroundInfluentialCharoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Self-citationThe immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
A dendrite method for cluster analysis
Caliński, T., & Harabasz, J. (1974) · Communications in Statistics · doi:10.1080/03610927408827101 · Cited by 4,480
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu450 · Cited by 3,113
T cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Histopathological Image Analysis: A Review
Gurcan, M. N., Boucheron, L. E., Can, A., Madabhushi, A., Rajpoot, N. M., & Yener, B. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2034865 · Cited by 2,052
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830 · cited 1×
“, 2016; Biswas and Mantovani, 2010), dendritic cells (Gardner and Ruffell, 2016), granulocytes (Coffelt et al., 2016), innate lymphoid cells (Crome et al.”
BackgroundTowards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
History of myeloid-derived suppressor cells
Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148
Mlecnik, B., Bindea, G., Angell, H. K., Maby, P., Angelova, M., Tougeron, D., Church, S. E., Lafontaine, L., Fischer, M., Fredriksen, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.025 · Cited by 1,034
Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636435 · Cited by 1,011 · cited 1×
“lymphocytes, FOXP3+ T lymphocytes (which we assume to be largely ‘regulatory’, although the role of FOXP3 is more complex (Wang et al., 2007) and CD68+ and CD163+ monocytes/macrophages.”
BackgroundRegulatory T cells in tumor immunity
Nishikawa, H., & Sakaguchi, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25429 · Cited by 944
Dendritic Cells and Cancer Immunity
Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 907
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shalapour, S., & Karin, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80007 · Cited by 698
Immune parameters affecting the efficacy of chemotherapeutic regimens
Zitvogel, L., Kepp, O., & Kroemer, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.223 · Cited by 669
Becht, E., de Reyniès, A., Giraldo, N. A., Pilati, C., Buttard, B., Lacroix, L., Selves, J., Sautès-Fridman, C., Laurent-Puig, P., & Fridman, W. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2879 · Cited by 590
Multi-class texture analysis in colorectal cancer histology
Kather, J. N., Weis, C.-A., Bianconi, F., Melchers, S. M., Schad, L. R., Gaiser, T., Marx, A., & Zöllner, F. G. (2016) · Scientific Reports · doi:10.1038/srep27988 · Cited by 578
Self-citationTsujikawa, T., Kumar, S., Borkar, R. N., Azimi, V., Thibault, G., Chang, Y. H., Balter, A., Kawashima, R., Choe, G., Sauer, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.037 · Cited by 568
Halama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.005 · Cited by 495
Self-citationClassification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J.-M. B.-S., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 468
Self-citationHalama, N., Michel, S., Kloor, M., Zoernig, I., Benner, A., Spille, A., Pommerencke, T., von Knebel, D. M., Folprecht, G., Luber, B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0268 · Cited by 420
Self-citationMechanisms regulating T-cell infiltration and activity in solid tumors
Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369
Landscape of tumor-infiltrating T cell repertoire of human cancers
Li, B., Li, T., Pignon, J.-C., Wang, B., Wang, J., Shukla, S. A., Dou, R., Chen, Q., Hodi, F. S., Choueiri, T. K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3581 · Cited by 306
Denkert, C., Wienert, S., Poterie, A., Loibl, S., Budczies, J., Badve, S., Bago-Horvath, Z., Bane, A., Bedri, S., Brock, J., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.109 · Cited by 285
Wong, M. T., Ong, D. E. H., Lim, F. S. H., Teng, K. W. W., McGovern, N., Narayanan, S., Ho, W. Q., Cerny, D., Tan, H. K. K., Anicete, R., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.007 · Cited by 241
Becht, E., Giraldo, N. A., Germain, C., de Reyniès, A., Laurent-Puig, P., Zucman-Rossi, J., Dieu-Nosjean, M.-C., Sautès-Fridman, C., & Fridman, W. H. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.12.002 · Cited by 213
The Immune Microenvironment of Human Tumors: General Significance and Clinical Impact
Fridman, W. H., Dieu‐Nosjean, M., Pagès, F., Cremer, I., Damotte, D., Sautès‐Fridman, C., & Galon, J. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0124-9 · Cited by 178
Cancer immune contexture and immunotherapy
Becht, É., Giraldo, N. A., Dieu‐Nosjean, M., Sautès‐Fridman, C., & Fridman, W. H. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.009 · Cited by 175
Genomics and emerging biomarkers for immunotherapy of colorectal cancer
Kather, J. N., Halama, N., & Jaeger, D. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.010 · Cited by 173
Self-citationLong-Term Risk of Colorectal Cancer After Negative Colonoscopy
Brenner, H., Chang-Claude, J. C., Seiler, C. M., & Hoffmeister, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9307 · Cited by 153
Self-citationNatural killer cells regulate diverse T cell responses
Crome, S. Q., Lang, P. A., Lang, K. S., & Ohashi, P. S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.002 · Cited by 152
A distinct innate lymphoid cell population regulates tumor-associated T cells
Crome, S. Q., Nguyen, L. T., López‐Vergès, S., Yang, S. Y. C., Martin, B. G., Yam, J. Y., Johnson, D. J., Nie, J., Pniak, M., Yen, P. H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4278 · Cited by 151
Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells
Newell, E. W., & Davis, M. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2783 · Cited by 140
Hoffmeister, M., Jansen, L., Rudolph, A., Tóth, C., Kloor, M., Roth, W., Bläker, H., Chang-Claude, J. C., & Brenner, H. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv045 · Cited by 123
Self-citationIn Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer
Kather, J. N., Poleszczuk, J., Suarez‐Carmona, M., Krisam, J., Charoentong, P., Valous, N. A., Weis, C., Tavernar, L., Leiß, F., Herpel, E., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2006 · Cited by 111
Self-citationSystems immune monitoring in cancer therapy
Greenplate, A. R., Johnson, D. B., Ferrell, P. B., & Irish, J. M. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.03.085 · Cited by 49
Kather, J. N., Charoentong, P., Suarez‐Carmona, M., Herpel, E., Klupp, F., Ulrich, A. B., Schneider, M., Zoernig, I., Luedde, T., Jaeger, D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1126 · Cited by 43
Self-citationTailoring Natural Killer cell immunotherapy to the tumour microenvironment
Barrow, A. D., & Colonna, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.001 · Cited by 38
Systems Biology Analysis of Heterocellular Signaling
Tape, C. J. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.016 · Cited by 30
Newell, E. W., & Becht, É. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0519 · Cited by 16
Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy
Kather, J. N., Berghoff, A. S., Ferber, D., Suarez‐Carmona, M., Reyes‐Aldasoro, C. C., Valous, N. A., Moraleda, R. R., Jäger, D., & Halama, N. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1444412 · Cited by 16
Self-citation
Research works printed but not linked: 1
- Glaire, 2018, Tumour-infiltrating CD8 + lymphocytes as a prognostic marker in colorectal cancer: A retrospective, pooled analysis of the QUASAR2 and VICTOR trials., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36, 3515, 10.1200/JCO.2018.36.15_suppl.3515 · doi:10.1200/jco.2018.36.15_suppl.3515
Cited by
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
Schürch, C. M., Bhate, S. S., Barlow, G. L., Phillips, D. J., Noti, L., Zlobec, I., Chu, P., Black, S., Demeter, J., McIlwain, D. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.005 · Cited by 1,064
Pan-cancer integrative histology-genomic analysis via multimodal deep learning
Chen, R. J., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Noor, Z., Shaban, M., Shady, M., Williams, M., Joo, B., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.004 · Cited by 660
Dynamics and specificities of T cells in cancer immunotherapy
Oliveira, G., & Wu, C. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00560-y · Cited by 616
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Narunsky-Haziza, L., Sepich-Poore, G. D., Livyatan, I., Asraf, O., Martino, C., Nejman, D., Gavert, N., Stajich, J. E., Amit, G., González, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.005 · Cited by 538
“Although our data do not establish causal relationships behind these clusters, they suggest that fungi are sparse but immunologically potent, analogous to PD1 cells in immunotherapy (Kather et al., 2018).”
Background
Metadata
- Authors
- Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., Schott, S., Zörnig, I., Utikal, J., Marx, A., Gaiser, T., Brenner, H., Chang-Claude, J., Hoffmeister, M., Jäger, D., & Halama, N.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2018-09-04
- Volume
- 7
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2892047621
- Cited by
- 280
- References
- 55
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- Heidelberg School of Oncology
- Bundesministerium für Bildung und Forschung
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.